查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587153

临床实验包装市场：按包装类型、材料类型和最终用户划分 - 2025-2030 年全球预测

Clinical Trial Packaging Market by Packaging Type (Bags & Pouches, Blisters, Bottles), Material Type (Corrugated Fiber, Glass, Metal), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床实验包装市场价值为12.6亿美元，预计到2024年将达到13.6亿美元，复合年增长率为8.22%，到2030年预计将达到21.9亿美元。

临床实验包装透过确保药物在测试过程中的完整性、安全性和合规性，在製药业中发挥至关重要的作用。临床实验包装涵盖运输和储存临床实验药物所需的包装解决方案的设计、开发和供应链管理。主要应用包括药品的安全包装、防篡改标籤以及确保患者的依从性和剂量准确性。最终用途领域主要包括製药和生物技术公司、委託研究组织以及相关医疗机构。市场成长的主要驱动力是由于慢性病的增加、治疗需求的多样化以及研发投资的增加而导致全球临床试验的不断扩大。新的商机包括个人化医疗，这需要客製化的包装解决方案，并且随着精准医疗的普及而不断扩大。包装中的数位集成，例如用于即时追踪和合规性监控的 RFID 技术和智慧标籤，也提供了潜在的成长途径。然而，监管挑战、严格的合规标准以及开发复杂包装解决方案的高成本都是限制因素。此外，世界各地不同的监管情况使产品标准化变得复杂，并给市场参与企业带来了挑战。随着环境问题的日益严重，为了利用成长机会，企业应该专注于永续和环保的包装材料。创新领域包括智慧包装技术，可增强追踪和监控能力并提高合规性和患者安全。该市场的竞争和创新主导性质要求技术和设计不断进步，以满足监管要求和消费者期望。透过正确解决这些方面，公司可以灵活地应对不断变化的市场动态，并明智地投资研发，以引领下一代临床实验包装解决方案。

主要市场统计
基准年[2023] 12.6亿美元
预测年份 [2024] 13.6亿美元
预测年份 [2030] 21.9亿美元
复合年增长率（%） 8.22%

市场动态：快速发展的临床实验包装市场的关键市场洞察

供需的动态交互作用正在改变临床实验包装市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球对临床试验包装永续包装的需求不断增长
    • 临床试验产品的储存与保护需求
    • 新药认证增加
  • 市场限制因素
    • 发展中地区缺乏现代化基础设施
  • 市场机会
    • 加大新药研发投入
    • 介绍创新的药品包装，包括折断式安瓿和吹灌封
  • 市场挑战
    • 缺乏训练有素的人员

波特五力：驾驭临床实验包装市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解临床实验包装市场的外部影响

外部宏观环境因素在塑造临床实验包装市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解临床实验包装市场的竞争状况

对临床实验包装市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵临床实验包装市场供应商的绩效评估

FPNV定位矩阵是评估临床实验包装市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製临床实验试验包装市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对临床实验包装市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球临床试验包装对永续包装的需求正在增加
      • 临床试验产品的储存与保护需求
      • 新药核准增加
    • 抑制因素
      • 发展中地区缺乏现代化基础设施
    • 机会
      • 加大新药研发投入
      • 介绍创新的药品包装，例如折断式安瓿和吹灌封口
    • 任务
      • 缺乏训练有素的人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章临床实验包装市场：依包装类型

  • 包包
  • 水泡
  • 瓶子
  • 套件或包
  • 小袋
  • 注射器
  • 管子
  • 管瓶和安瓿

第七章依材料类型临床实验包装市场

  • 波纹纤维
  • 玻璃
  • 金属
  • 纸
  • 塑胶

第八章临床实验包装市场：依最终使用者分类

  • 临床研究组织
  • 药品生产设施
  • 研究室

第九章美洲临床实验包装市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太临床实验包装市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲临床实验包装市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alcami Corporation, Inc.
  • Almac Group Limited
  • Bilcare Limited
  • Corden Pharma Gmbh
  • Fisher Clinical Services
  • Lonza Group
  • Parexel International Corporation by Phoenix Parentco, Inc.
  • Piramal Enterprises Ltd.
  • Sharp Clinical Services, Inc
  • Societal CDMO
  • Symbiosis Pharmaceutical Services
  • The Coghlan Group
  • Westrock Company
  • Xerimis Inc.
  • Yourway Transport Inc.
Product Code: MRR-4311CE1A33A7

The Clinical Trial Packaging Market was valued at USD 1.26 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 8.22%, to USD 2.19 billion by 2030.

Clinical trial packaging plays a crucial role in the pharmaceutical industry, ensuring the integrity, safety, and compliance of drug products during testing phases. The scope of clinical trial packaging encompasses the design, development, and supply chain management of packaging solutions required for transporting and storing investigational drugs. Key applications include secure packaging of pharmaceuticals, tamper-evident labeling, and enabling patient compliance and dosage accuracy. End-use sectors predominantly involve pharmaceutical and biotechnology companies, contract research organizations, and associated healthcare facilities. A major driver for market growth is the continuous expansion of clinical trials worldwide, resulting from rising chronic diseases, diverse therapeutic needs, and increased investments in R&D. An emerging opportunity is personalized medicine requiring customized packaging solutions, which is expanding as precision medicine gains traction. Digital integration in packaging, such as RFID technology and smart labels for real-time tracking and compliance monitoring, also presents potential growth avenues. However, regulatory challenges, stringent compliance standards, and high costs in developing sophisticated packaging solutions act as limitations. Additionally, the varying global regulatory landscapes complicate product standardization, posing a challenge for market participants. To capitalize on growth opportunities, companies should focus on sustainable and eco-friendly packaging materials, as environmental concerns become more pressing. Innovation areas include smart packaging technologies that enhance tracking and monitoring capabilities, improving both compliance and patient safety. The nature of this market is highly competitive and innovation-driven, demanding continuous advancements in technology and design to meet regulatory demands and consumer expectations. Proper addressing of these aspects can lead to significant business opportunities, provided companies remain agile and responsive to changing market dynamics, investing smartly in research and development to lead in next-generation clinical trial packaging solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.26 billion
Estimated Year [2024] USD 1.36 billion
Forecast Year [2030] USD 2.19 billion
CAGR (%) 8.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Packaging Market

The Clinical Trial Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for sustainable packaging for clinical trials packaging globally
    • Demand for storage and protection of clinical study products
    • Increasing approval of novel drugs
  • Market Restraints
    • Dearth of modern infrastructure in developing regions
  • Market Opportunities
    • Increasing investment on research and development of new drugs
    • Introduction of innovative pharmaceutical packaging, including snap off ampoules and blow fill seals
  • Market Challenges
    • Dearth of trained personnel

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Packaging Market

A detailed market share analysis in the Clinical Trial Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Packaging Market

A strategic analysis of the Clinical Trial Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Packaging Market, highlighting leading vendors and their innovative profiles. These include Alcami Corporation, Inc., Almac Group Limited, Bilcare Limited, Corden Pharma Gmbh, Fisher Clinical Services, Lonza Group, Parexel International Corporation by Phoenix Parentco, Inc., Piramal Enterprises Ltd., Sharp Clinical Services, Inc, Societal CDMO, Symbiosis Pharmaceutical Services, The Coghlan Group, Westrock Company, Xerimis Inc., and Yourway Transport Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Packaging Type, market is studied across Bags & Pouches, Blisters, Bottles, Kits or Packs, Sachets, Syringes, Tubes, and Vials & Ampoules.
  • Based on Material Type, market is studied across Corrugated Fiber, Glass, Metal, Paper, and Plastic.
  • Based on End-User, market is studied across Clinical Research Organization, Drug Manufacturing Facilities, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for sustainable packaging for clinical trials packaging globally
      • 5.1.1.2. Demand for storage and protection of clinical study products
      • 5.1.1.3. Increasing approval of novel drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of modern infrastructure in developing regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment on research and development of new drugs
      • 5.1.3.2. Introduction of innovative pharmaceutical packaging, including snap off ampoules and blow fill seals
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of trained personnel
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Packaging Market, by Packaging Type

  • 6.1. Introduction
  • 6.2. Bags & Pouches
  • 6.3. Blisters
  • 6.4. Bottles
  • 6.5. Kits or Packs
  • 6.6. Sachets
  • 6.7. Syringes
  • 6.8. Tubes
  • 6.9. Vials & Ampoules

7. Clinical Trial Packaging Market, by Material Type

  • 7.1. Introduction
  • 7.2. Corrugated Fiber
  • 7.3. Glass
  • 7.4. Metal
  • 7.5. Paper
  • 7.6. Plastic

8. Clinical Trial Packaging Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Research Organization
  • 8.3. Drug Manufacturing Facilities
  • 8.4. Research Laboratories

9. Americas Clinical Trial Packaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trial Packaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trial Packaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcami Corporation, Inc.
  • 2. Almac Group Limited
  • 3. Bilcare Limited
  • 4. Corden Pharma Gmbh
  • 5. Fisher Clinical Services
  • 6. Lonza Group
  • 7. Parexel International Corporation by Phoenix Parentco, Inc.
  • 8. Piramal Enterprises Ltd.
  • 9. Sharp Clinical Services, Inc
  • 10. Societal CDMO
  • 11. Symbiosis Pharmaceutical Services
  • 12. The Coghlan Group
  • 13. Westrock Company
  • 14. Xerimis Inc.
  • 15. Yourway Transport Inc.

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL PACKAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL TRIAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL PACKAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAGS & POUCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BLISTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY KITS OR PACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIALS & AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CORRUGATED FIBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PAPER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DRUG MANUFACTURING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. CLINICAL TRIAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023